Moderna, Inc.MRNANASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank78
3Y CAGR+0.9%
5Y CAGR+22.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.9%/yr
vs +155.9%/yr prior
5Y CAGR
+22.1%/yr
Recent deceleration
Acceleration
-154.9pp
Decelerating
Percentile
P78
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.15B | -26.9% |
| 2024 | $5.68B | -11.2% |
| 2023 | $6.39B | +58.3% |
| 2022 | $4.04B | +121.6% |
| 2021 | $1.82B | +19.4% |
| 2020 | $1.53B | +165.7% |
| 2019 | $574.91M | +510.0% |
| 2018 | $94.25M | -79.3% |
| 2017 | $454.64M | +43.4% |
| 2016 | $317.05M | - |